Nautilus Biotechnology Inc (NAUT)
2.69
+0.02
(+0.75%)
USD |
NASDAQ |
May 03, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Price: 2.69 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.78 | 2.82 | 2.64 | 2.69 | 65304.00 |
May 02, 2024 | 2.81 | 2.81 | 2.67 | 2.67 | 73901.00 |
May 01, 2024 | 2.59 | 2.90 | 2.53 | 2.78 | 107897.0 |
Apr 30, 2024 | 2.65 | 3.00 | 2.47 | 2.54 | 190123.0 |
Apr 29, 2024 | 2.54 | 2.64 | 2.47 | 2.57 | 53173.00 |
Apr 26, 2024 | 2.42 | 2.52 | 2.351 | 2.49 | 30030.00 |
Apr 25, 2024 | 2.40 | 2.60 | 2.32 | 2.36 | 85838.00 |
Apr 24, 2024 | 2.50 | 2.569 | 2.40 | 2.40 | 44228.00 |
Apr 23, 2024 | 2.45 | 2.58 | 2.45 | 2.49 | 24937.00 |
Apr 22, 2024 | 2.49 | 2.49 | 2.400 | 2.42 | 31663.00 |
Apr 19, 2024 | 2.31 | 2.46 | 2.31 | 2.46 | 52503.00 |
Apr 18, 2024 | 2.44 | 2.508 | 2.33 | 2.34 | 99733.00 |
Apr 17, 2024 | 2.57 | 2.57 | 2.43 | 2.43 | 76429.00 |
Apr 16, 2024 | 2.46 | 2.610 | 2.46 | 2.52 | 61444.00 |
Apr 15, 2024 | 2.52 | 2.64 | 2.426 | 2.46 | 52184.00 |
Apr 12, 2024 | 2.62 | 2.627 | 2.45 | 2.47 | 72720.00 |
Apr 11, 2024 | 2.52 | 2.67 | 2.52 | 2.63 | 61434.00 |
Apr 10, 2024 | 2.60 | 2.69 | 2.540 | 2.56 | 109752.0 |
Apr 09, 2024 | 2.72 | 2.78 | 2.62 | 2.63 | 29367.00 |
Apr 08, 2024 | 2.67 | 2.75 | 2.66 | 2.70 | 34010.00 |
Apr 05, 2024 | 2.64 | 2.75 | 2.62 | 2.67 | 95215.00 |
Apr 04, 2024 | 2.78 | 2.79 | 2.62 | 2.64 | 83389.00 |
Apr 03, 2024 | 2.69 | 2.80 | 2.69 | 2.77 | 62042.00 |
Apr 02, 2024 | 2.96 | 2.960 | 2.63 | 2.71 | 63301.00 |
Apr 01, 2024 | 2.90 | 3.07 | 2.89 | 3.00 | 55032.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.55
Minimum
Dec 16 2022
22.43
Maximum
Feb 08 2021
5.482
Average
3.54
Median
May 27 2022
Price Benchmarks
Amicus Therapeutics Inc | 10.40 |
Geron Corp | 3.93 |
TG Therapeutics Inc | 16.19 |
Editas Medicine Inc | 5.67 |
G1 Therapeutics Inc | 4.49 |
Price Related Metrics
Price to Book Value | 1.351 |
Earnings Yield | -20.45% |
Market Cap | 336.96M |